Ftse Mib
37.055,70
-0,18%
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
NASDAQ
19.523,40
-1,36%
Bitcoin
96.419,67
-0,13%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Viracta Therapeutics Inc (VIRX) Viracta Therapeutics Inc (VIRX) Notizie

Viracta Therapeutics Inc

VIRX
0,0301
0,00 (0,00%)
07 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/2/202523:00EDGAR2Form 8-K - Current report
05/2/202523:00GLOBEViracta Therapeutics Announces Wind Down of Operations
31/1/202522:30EDGAR2Form 8-K - Current report
24/1/202523:14EDGAR2Form 8-K - Current report
17/1/202522:08EDGAR2Form 8-K - Current report
26/12/202422:39EDGAR2Form 8-K - Current report
26/12/202422:30GLOBEViracta Therapeutics Announces Closure of NAVAL-1 Clinical..
29/11/202423:14EDGAR2Form 8-K - Current report
27/11/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202423:20EDGAR2Form 8-K - Current report
13/11/202413:30EDGAR2Form 8-K - Current report
13/11/202413:00GLOBEViracta Therapeutics Reports Third Quarter 2024 Financial..
06/11/202422:46EDGAR2Form 8-K - Current report
06/11/202422:30GLOBEViracta Therapeutics Announces Reprioritization of Resources..
13/9/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202413:00GLOBEViracta Therapeutics to Present at the H.C. Wainwright 26th..
14/8/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202413:15EDGAR2Form 8-K - Current report
14/8/202413:05GLOBEViracta Therapeutics Reports Second Quarter 2024 Financial..
14/8/202413:00GLOBEViracta Therapeutics Announces Positive Data from the Phase..
31/5/202422:46EDGAR2Form 8-K - Current report
30/5/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:05GLOBEViracta Therapeutics Announces New Employment Inducement..
16/5/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/5/202422:34EDGAR2Form 8-K - Current report
14/5/202413:00GLOBEViracta Therapeutics Appoints Michael Faerm as Chief..
09/5/202423:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:34EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEViracta Therapeutics Reports First Quarter 2024 Financial..
07/5/202422:05GLOBEViracta Therapeutics to Present at the RBC Capital Markets..
15/4/202414:00GLOBEViracta Therapeutics Announces Positive Topline Nana-val..
01/4/202414:30GLOBEViracta Therapeutics to Present Topline Nana-val Results..
07/3/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202422:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202422:12EDGAR2Form 8-K - Current report
07/3/202422:05GLOBEViracta Therapeutics Reports Fourth Quarter and Full Year..
29/2/202414:00GLOBEViracta Therapeutics Announces Completion of Second-Stage..
28/2/202402:40EDGAR2Form 144 - Report of proposed sale of securities
28/2/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202403:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
Apertura: Min: Max:
Chiusura: 0,0301

La tua Cronologia

NASDAQ
VIRX
Viracta Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci